Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% | -.--% | -.--% |
2019 | Roivant Sciences GmbH cancelled the acquisition of substantially all of the assets from PhaseRx, Inc. | CI |
2018 | PhaseRx, Inc. Bankruptcy Case Dismissed | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.34T | |
+19.25% | 13TCr | |
+14.16% | 11TCr | |
-4.36% | 2.46TCr | |
+2.94% | 2.28TCr | |
-10.21% | 1.82TCr | |
-41.48% | 1.65TCr | |
-11.75% | 1.65TCr | |
+3.18% | 1.34TCr | |
+27.15% | 1.11TCr |
- Stock Market
- Equities
- PZRXQ Stock
- News PhaseRx, Inc.
- PhaseRx, Inc. has completed an IPO in the amount of $18.5 million.